SGLT2 Inhibitors Associated with Lower Risk of Sight-Threate

SGLT2 inhibitors show a reduced risk of retinopathy compared with DPP-4 inhibitors, pioglitazone, and sulfonylureas among patients with type 2 diabetes.

Related Keywords

Taiwan , Taipei , T Ai Pei , , Unsplash Perchek Industries , National Health Insurance Research Database , Chii Min Hwu , Taipei Veterans General , National Health Insurance Research ,